CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 311103425
- Phone
- (617) 798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 89 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2008-12-31 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +345,800 | $0.14 | $48K | 8,380,192 |
| 2008-12-31 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +227,100 | $0.14 | $32K | 8,261,492 |
| 2008-12-30 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +183,300 | $0.12 | $22K | 8,034,392 |
| 2008-12-30 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +183,300 | $0.12 | $22K | 8,034,392 |
| 2008-12-30 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +183,300 | $0.12 | $22K | 8,034,392 |
| 2008-12-29 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +115,400 | $0.11 | $13K | 7,851,092 |
| 2008-12-29 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +115,400 | $0.11 | $13K | 7,918,992 |
| 2008-12-29 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +115,400 | $0.11 | $13K | 7,918,992 |
| 2008-12-24 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +24,965 | $0.12 | $3K | 7,735,692 |
| 2008-12-23 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +21,000 | $0.15 | $3K | 7,710,727 |
| 2008-12-19 | ARLEN GARY H Director | Purchase | +10,000 | $0.12 | $1K | 10,450 |
| 2008-12-17 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +250,000 | $0.12 | $30K | 7,588,727 |
| 2008-12-17 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +101,000 | $0.12 | $12K | 7,689,727 |
| 2008-12-16 | Farricielli Joseph J. Jr. Director | Purchase | +10,000 | $0.11 | $1K | 76,000 |
| 2008-12-12 | Berg Jeffrey Alan Director | Purchase | +1,250,000 | $0.13 | $163K | 5,445,600 |
| 2008-12-12 | Berg Jeffrey Alan Director | Purchase | +1,250,000 | $0.13 | $163K | 5,469,600 |
| 2008-12-11 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +120,700 | $0.12 | $14K | 7,338,727 |
| 2008-12-10 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +85,100 | $0.12 | $10K | 7,218,027 |
| 2008-12-09 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +70,000 | $0.12 | $8K | 7,132,927 |
| 2008-12-04 | Farricielli Joseph J. Jr. Director | Purchase | +10,000 | $0.11 | $1K | 66,000 |
Page 31 of 33 · 657 trades